1. Home
  2. SHO vs ZYME Comparison

SHO vs ZYME Comparison

Compare SHO & ZYME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sunstone Hotel Investors Inc. Sunstone Hotel Investors Inc.

SHO

Sunstone Hotel Investors Inc. Sunstone Hotel Investors Inc.

N/A

Current Price

$12.77

Market Cap

2.3B

ML Signal

N/A

Logo Zymeworks Inc.

ZYME

Zymeworks Inc.

N/A

Current Price

$26.31

Market Cap

2.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SHO
ZYME
Founded
1995
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Hotels/Resorts
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.3B
2.0B
IPO Year
2004
2022

Fundamental Metrics

Financial Performance
Metric
SHO
ZYME
Price
$12.77
$26.31
Analyst Decision
Hold
Strong Buy
Analyst Count
12
13
Target Price
$12.40
★ $43.23
AVG Volume (30 Days)
★ 3.1M
1.2M
Earning Date
11-06-2026
11-09-2026
Dividend Yield
★ 2.83%
N/A
EPS Growth
N/A
★ 33.33
EPS
0.43
★ 1.08
Revenue
★ $1,115,167,000.00
$105,965,000.00
Revenue This Year
$4.56
$216.20
Revenue Next Year
N/A
$7.81
P/E Ratio
$29.64
★ $24.65
Revenue Growth
N/A
★ 38.87
52 Week Low
$8.69
$21.52
52 Week High
$13.08
$31.97

Technical Indicators

Market Signals
Indicator
SHO
ZYME
Relative Strength Index (RSI) 60.39 41.75
Support Level $12.19 $25.21
Resistance Level $13.08 $27.40
Average True Range (ATR) 0.28 1.41
MACD -0.05 -0.33
Stochastic Oscillator 61.80 5.69

Price Performance

Historical Comparison
SHO
ZYME

About SHO Sunstone Hotel Investors Inc. Sunstone Hotel Investors Inc.

Sunstone Hotel Investors Inc is a real estate investment trust that acquires, owns, manages, and renovates the full-service hotel and select-service hotel properties across various states in the United States. Its firm's portfolio consists upper upscale and luxury hotels located in convention, resort destination and urban markets. Its majority of the hotels operate under a brand owned by Marriott, Hilton, Hyatt, Four Seasons or Montage. It operates geographically in California which generates the majority of its revenue; Florida; and Hawaii. The company's sole source of income is hotel revenue from its Hotel Ownership Segment.

About ZYME Zymeworks Inc.

Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Its suite of therapeutic platforms and its fully integrated drug development engine enables precise engineering of differentiated therapeutic product candidates. Its clinical candidate, zanidatamab, is a novel HER2-targeted bispecific antibody currently being evaluated in multiple Phase 1, Phase 2, and pivotal clinical trials globally as a targeted treatment option for patients with solid tumors that express HER2. It is also advancing a deep preclinical pipeline in oncology and other therapeutic areas.

Share on Social Networks: